An Open-label Phase 1b/2 Study Assessing the Safety and Efficacy of Mitazalimab in Combination with Chemotherapy in Patients with Metastatic Pancreatic Ductal Adenocarcinoma
Latest Information Update: 13 Jun 2025
At a glance
- Drugs Fluorouracil (Primary) ; Folinic acid (Primary) ; Gemcitabine (Primary) ; Irinotecan (Primary) ; Mitazalimab (Primary) ; Oxaliplatin (Primary) ; Paclitaxel (Primary)
- Indications Adenocarcinoma; Pancreatic ductal carcinoma
- Focus Adverse reactions; Registrational; Therapeutic Use
- Acronyms OPTIMIZE-1
- Sponsors Alligator Bioscience
Most Recent Events
- 03 Jun 2025 Results presented in the Alligator Biosciences Media Release.
- 03 Jun 2025 According to Alligator Biosciences media release, biomarker data from this trial were presented at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting.
- 23 May 2025 According to Alligator Biosciences media release, data from this trial will be presented at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting.